XSHG
603360
Market cap1.53bUSD
Jul 10, Last price
14.86CNY
1D
1.16%
1Q
-44.88%
IPO
178.28%
Name
Dalian BIO-CHEM Co Ltd
Chart & Performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Established in 2003 and headquartered in Dalian, China, Dalian BIO-CHEM Company Limited specializes in the manufacture and distribution of antimicrobial agents, specifically bactericides, antiseptics, and fungicides. These products serve a broad spectrum of industrial sectors across continents, including Europe, North and South America, the Middle East, Africa, and Asia. The company's offerings perform various crucial functions: they act as disinfectants and effective algaecides for water treatment systems in industries like petrochemicals, power generation, central air conditioning, and industrial cooling. Additionally, they provide corrosion protection within aqueous systems, found in products such as emulsions, mineral slurries, pigment dispersions, adhesives, tackifiers, metalworking fluids, and cosmetics. Their solutions also extend to the aqueous formulations used in leather, paints, coatings, textiles, and dyeing processes. Furthermore, Dalian BIO-CHEM's products combat mildew and algae, and the company offers a specialized dry film preservative tailored for paints and coatings.
Valuation
Title CNY in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||